Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
Takanori Mizoguchi,1 Mineo Ozaki,2 Nobuchika Ogino3 1Mizoguchi Eye Clinic, Ophthalmology, Sasebo, Japan; 2Ozaki Eye Hospital, Ophthalmology, Miyazaki, Japan; 3Nishigaki Eye Clinic, Ophthalmology, Nagoya, Japan Purpose: To evaluate the efficacy and safety of 0.05% epinastine and 0.1% olopatadine ey...
Enregistré dans:
Auteurs principaux: | Mizoguchi T, Ozaki M, Ogino N |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bbb1fa0597144a6599e344fca39bab0a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
par: McLaurin E, et autres
Publié: (2017) -
Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
par: Azadeh Dorostkar, et autres
Publié: (2021) -
Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies
par: Meier E, et autres
Publié: (2017) -
Size-Segregated Particulate Matter Down to PM<sub>0.1</sub> and Carbon Content during the Rainy and Dry Seasons in Sumatra Island, Indonesia
par: Muhammad Amin, et autres
Publié: (2021) -
Prevalencia de síntomas de rinitis alérgica y su relación con factores de riesgo en escolares de Santiago, Chile
par: Caussade L,Solange, et autres
Publié: (2006)